Aldeyra Therapeutics (NasdaqCM:ALDX) 2025 Conference Transcript

Aldeyra Therapeutics (NasdaqCM:ALDX) 2025 Conference November 20, 2025 06:30 AM ET Company ParticipantsTodd Brady - CEOTodd Brady - President and CEOConference Call ParticipantsClara Dunn - Biotech AnalystClara DunnTo Jefferies Healthcare Conference in London. My name is Clara Dunn. I am one of the biotech analysts here at Jefferies. Thank you for joining this session with Aldeyra Therapeutics. I am joined by Dr. Todd Brady, President and Chief Executive Officer of Aldeyra. Welcome, Todd.Todd BradyThanks, C ...